{"DataElement":{"publicId":"7544346","version":"1","preferredName":"Seizure Disease Present ICANS Seizure Grade","preferredDefinition":"A description of the ICANS seizure grade.","longName":"2528155v1.0:7544343v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2528155","version":"1","preferredName":"Seizure Disease Present","preferredDefinition":"information related to the presence of seizure, a sudden, involuntary skeletal muscular contractions of cerebral or brain stem origin, that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person.","longName":"SEIZ_DZ_PRES","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2528153","version":"1","preferredName":"Seizure Diseases and Disorders","preferredDefinition":"the most dramatic type of seizure, characterized by tonic and clonic contraction of most skeletal muscles.:A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C2962:C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Seizure","conceptCode":"C2962","definition":"Sudden, involuntary skeletal muscular contractions of cerebral or brain stem origin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2004109A-EBA2-0652-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-17","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-10-17","modifiedBy":"ONEDATA","dateModified":"2006-10-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233878","version":"1","preferredName":"Present","preferredDefinition":"Being or existing in a specified place or at the specified time.","longName":"C25626","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F970CDF6-F829-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008571","version":"1","preferredName":"Chronic or Associated Diseases and Exposures","preferredDefinition":"chronic diseases, as well as diseases and exposures associated with cancer.","longName":"CHR_O_ASS_DZ_AND_EXP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9B9249B-AB81-2F8D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-03-25","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-03-25","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2004109A-EBB0-0652-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-10-17","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7544343","version":"1","preferredName":"Immune Effector Cell Associated Neurotoxicity Syndrome Seizure Grade","preferredDefinition":"Neurotoxicity associated with immune effector cell therapy. It may be characterized by aphasia, altered level of consciousness, motor weakness, seizures, and cerebral edema._Sudden, involuntary skeletal muscular contractions of cerebral or brain stem origin._A position on a scale of intensity or amount or quality.","longName":"7544343v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Grade 4","valueDescription":"Grade 4 Seizure, ASTCT ICANS","ValueMeaning":{"publicId":"7544344","version":"1","preferredName":"Grade 4 Seizure, ASTCT ICANS","longName":"7544344","preferredDefinition":"Life-threatening prolonged seizure (>5 min); or repetitive clinical or electrical seizures without return to baseline in between seizures, as defined by the American Society for Transplantation and Cellular Therapy (ASTCT) and the Immune Effector Cell Associated Neurotoxicity Syndrome (ICANS) Consensus Grading for Adults.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Grade 4 Seizure, ASTCT ICANS","conceptCode":"C176861","definition":"Life-threatening prolonged seizure (>5 min); or repetitive clinical or electrical seizures without return to baseline in between seizures, as defined by the American Society for Transplantation and Cellular Therapy (ASTCT) and the Immune Effector Cell Associated Neurotoxicity Syndrome (ICANS) Consensus Grading for Adults.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B817B465-DC37-56DE-E053-4EBD850AB070","latestVersionIndicator":"Yes","beginDate":"2021-01-04","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-01-04","modifiedBy":"TSESU","dateModified":"2023-03-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B817B465-DC50-56DE-E053-4EBD850AB070","beginDate":"2021-01-04","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-01-04","modifiedBy":"ONEDATA","dateModified":"2021-01-04","deletedIndicator":"No"},{"value":"Grade 3","valueDescription":"Grade 3 Seizure, ASTCT ICANS","ValueMeaning":{"publicId":"7544345","version":"1","preferredName":"Grade 3 Seizure, ASTCT ICANS","longName":"7544345","preferredDefinition":"Any clinical seizure focal or generalized that resolves rapidly or nonconvulsive seizures on EEG that resolve with intervention, as defined by the American Society for Transplantation and Cellular Therapy (ASTCT) and the Immune Effector Cell Associated Neurotoxicity Syndrome (ICANS) Consensus Grading for Adults.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Grade 3 Seizure, ASTCT ICANS","conceptCode":"C176860","definition":"Any clinical seizure focal or generalized that resolves rapidly or nonconvulsive seizures on EEG that resolve with intervention, as defined by the American Society for Transplantation and Cellular Therapy (ASTCT) and the Immune Effector Cell Associated Neurotoxicity Syndrome (ICANS) Consensus Grading for Adults.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B817B465-DC5C-56DE-E053-4EBD850AB070","latestVersionIndicator":"Yes","beginDate":"2021-01-04","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-01-04","modifiedBy":"TSESU","dateModified":"2023-03-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B817B465-DC75-56DE-E053-4EBD850AB070","beginDate":"2021-01-04","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-01-04","modifiedBy":"ONEDATA","dateModified":"2021-01-04","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7544342","version":"1","preferredName":"Immune Effector Cell Associated Neurotoxicity Syndrome Seizure Grade","preferredDefinition":"Neurotoxicity associated with immune effector cell therapy. It may be characterized by aphasia, altered level of consciousness, motor weakness, seizures, and cerebral edema.:Sudden, involuntary skeletal muscular contractions of cerebral or brain stem origin.:A position on a scale of intensity or amount or quality.","longName":"C162909:C2962:C48309","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune Effector Cell Associated Neurotoxicity Syndrome","conceptCode":"C162909","definition":"Neurotoxicity associated with immune effector cell therapy. It may be characterized by aphasia, altered level of consciousness, motor weakness, seizures, and cerebral edema.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Seizure","conceptCode":"C2962","definition":"Sudden, involuntary skeletal muscular contractions of cerebral or brain stem origin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Grade","conceptCode":"C48309","definition":"A position on a scale of intensity or amount or quality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B817B465-DC0E-56DE-E053-4EBD850AB070","latestVersionIndicator":"Yes","beginDate":"2021-01-04","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-01-04","modifiedBy":"ONEDATA","dateModified":"2021-01-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B817B465-DC1F-56DE-E053-4EBD850AB070","latestVersionIndicator":"Yes","beginDate":"2021-01-04","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-01-04","modifiedBy":"MALUMK","dateModified":"2021-01-28","changeDescription":"Released. 01/28/2021 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"CPST_TOX_seizure_severity","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the ICANS seizure gr","type":"Preferred Question Text","description":"What was the ICANS seizure grade?","url":null,"context":"NHLBI"},{"name":"Specify the severity of the seizure","type":"Application Standard Question Text","description":"Specify the severity of the seizure","url":null,"context":"NHLBI"},{"name":"Specify the severity of the seizure","type":"Alternate Question Text","description":"Specify the severity of the seizure","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B817B465-DC82-56DE-E053-4EBD850AB070","latestVersionIndicator":"Yes","beginDate":"2021-01-04","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-01-04","modifiedBy":"MALUMK","dateModified":"2021-06-03","changeDescription":"Released. 01/28/2021 KMM; System generated def displayed as alt def. ALT name added for 4100r6. 06/03/2021 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}